StonvexLoading…
StonvexStonvexStonvexCore line items from ASB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $1.10B | $1.24B | $1.06B | $1.28B |
Operating Income | $206.05M | $459.63M | $436.31M | $326.97M |
Net Income | $182.96M | $366.12M | $350.99M | $306.77M |
EPS (Diluted) | $1.13 | $2.34 | $2.18 | $1.86 |
Total Assets | $41.02B | $39.41B | $35.10B | $33.42B |
Total Liabilities | $36.84B | $35.39B | $31.08B | $29.33B |
Cash & Equivalents | $923.82M | $621.46M | $1.03B | $716.05M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 151.04M | 150.44M | 149.34M | 153.54M |